Medicare Enrolled

Dr. Diaa Osman, DO

Hematology & Oncology · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4101 JAMES CASEY ST STE 100, Austin, TX 78745
5124472202
In practice since 2007 (18 years)
NPI: 1689894495 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Osman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Osman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Osman

Dr. Diaa Osman is a hematology & oncology specialist in Austin, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Osman performed 9,459 Medicare services across 1,418 unique beneficiaries.

Between the years covered by Open Payments, Dr. Osman received a total of $650 from 13 pharmaceutical and/or device companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Osman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 37% volume in TX $650 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,459
Medicare services
Top 37% in TX for hematology & oncology
1,418
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~526 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based) 6,185 $0 $3
Blood draw (venipuncture) 587 $8 $20
Office visit, established patient (30-39 min) 399 $101 $368
Complete blood count (CBC) with differential 389 $8 $36
Comprehensive metabolic blood panel 331 $10 $64
Immunoglobulin level test 207 $9 $56
Office visit, established patient, complex (40-54 min) 139 $139 $496
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 133 $306 $2,762
Lactate dehydrogenase (enzyme) level 97 $6 $31
Hospital follow-up visit, high complexity 72 $95 $357
Measurement of immunoglobulin light chains 66 $17 $60
Microscopic examination for white blood cells with manual cell count 55 $4 $22
Complete blood count (CBC), automated 55 $6 $34
Reticulated (young) platelet measurement 50 $35 $143
Ct scan of chest with contrast 49 $57 $821
Ferritin level test (iron stores) 48 $13 $60
Iron level test 48 $6 $27
Iron binding capacity test 48 $9 $35
Office visit, established patient (20-29 min) 41 $63 $250
Red blood count, automated test 40 $4 $23
CT scan of abdomen and pelvis with contrast 39 $188 $1,067
Beta-2 microglobulin (protein) level 39 $16 $96
New patient office visit (45-59 min) 32 $128 $565
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev 32 $200 $700
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 28 $20 $128
Immunologic analysis technique on serum 27 $29 $108
Immunologic analysis technique on serum (immunofixation) 27 $22 $160
New patient office visit, complex (60-74 min) 27 $161 $709
Protein measurement, serum 26 $11 $99
Initial hospital admission, high complexity 25 $139 $694
Uric acid level test 18 $4 $25
Infusion, normal saline solution , 1000 cc 17 $2 $19
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 16 $92 $657
Nuclear medicine study from skull base to mid-thigh with ct scan 14 $1,251 $4,802
Infusion into a vein for hydration, 31-60 minutes 14 $27 $256
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 14 $50 $313
Ct scan of soft tissue of neck with contrast 13 $51 $658
Vitamin B-12 level test 12 $15 $76
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
66.9% medium
32.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$650
Total received (2018-2024)
Avg $130/year across 5 years
Bottom 23% in TX for hematology & oncology
13
Companies
18
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$599 (92.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51 (7.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$385
2023
$52
2022
$45
2021
$12
2018
$156

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tempus AI, Inc
$147
Ipsen Biopharmaceuticals, Inc
$113
Intera Oncology, Inc
$107
Daiichi Sankyo Inc.
$68
Novartis Pharmaceuticals Corporation
$53
Genentech USA, Inc.
$30
Stemline Therapeutics Inc.
$27
E.R. Squibb & Sons, L.L.C.
$22
PFIZER INC.
$22
Amgen Inc.
$17
Regeneron Healthcare Solutions, Inc.
$17
Celgene Corporation
$15
Gilead Sciences, Inc.
$12
Top 3 companies account for 56.5% of total payments
Associated products mentioned in payments ›
Alecensa · Blincyto · INLYTA · INTERA · LIBTAYO · Orserdu · PROMACTA · Revlimid · SCEMBLIX · Somatuline Depot · Vanflyta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Austin?
Compare hematology & oncology specialists in the Austin area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
26
Per 100K population
2.0
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Osman is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Osman experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Osman performed 6,185 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Osman receive payments from pharmaceutical companies?
Yes. Dr. Osman received a total of $650 from 13 companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Osman's costs compare to other hematology & oncology specialists in Austin?
Dr. Osman's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Osman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →